KRAS and intrahepatic cholangiocarcinoma: In this study, we have established a novel autochthonous mouse model of ICC that incorporates bi-allelic Bap1 deletion in conjunction with expression of mutant Kras within the Albumin-expressing progenitor population in the developing liver.